Compile Data Set for Download or QSAR
maximum 50k data
Found 316 Enz. Inhib. hit(s) with Target = 'Histone-lysine N-methyltransferase SUV39H2'
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423017(US10508109, Example 203 | dimethyl (4-(2-(5-chloro...)
Affinity DataIC50:  1.77nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423023(3-(2-(7-(1,4-diazepan-1- yl)imidazo[1,2-a]pyridine...)
Affinity DataIC50:  2.07nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423039(N1-(2-(5-chloro-2,4- dimethoxyphenyl)-7-(4- (cyclo...)
Affinity DataIC50:  2.20nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422884(N1-(2-(5-chloro-2,4- dimethoxyphenyl)-7- methoxyim...)
Affinity DataIC50:  2.71nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423024(US10508109, Example 210 | diethyl (2-(4-(2-(5-chlo...)
Affinity DataIC50:  2.90nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422944(3-(4-(2-(5-bromo-2,4- dimethoxyphenyl)imidazo[1,2-...)
Affinity DataIC50:  3nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422805(2-(5-chloro-2,4- dimethoxyphenyl)-7-(pyrrolidin- 1...)
Affinity DataIC50:  3.10nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422936(N-(1-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2...)
Affinity DataIC50:  3.27nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423089(US10508109, Example 275 | tert-butyl 4-(2-(5-chlor...)
Affinity DataIC50:  3.33nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422898(N1-(2-(5-chloro-2,4- dimethoxyphenyl)-7- morpholin...)
Affinity DataIC50:  3.35nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422945(4-(2-(4-(2-(5-bromo-2,4- dimethoxyphenyl)imidazo[1...)
Affinity DataIC50:  3.49nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422972(3-(4-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2...)
Affinity DataIC50:  3.53nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422858(2,4-dimethoxy-5-(7-(pyrrolidin- 1-yl)imidazo[1,2-a...)
Affinity DataIC50:  3.71nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422849(N-(1-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2...)
Affinity DataIC50:  3.81nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422872(N-(1-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2...)
Affinity DataIC50:  3.95nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422847(1-(1-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2...)
Affinity DataIC50:  4.11nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423052((4-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2- ...)
Affinity DataIC50:  4.16nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422887(N1-(2-(5-chloro-2,4- dimethoxyphenyl)-7- methylimi...)
Affinity DataIC50:  4.31nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423003(2-(5-chloro-2,4- dimethoxyphenyl)-7-(1,4- diazepan...)
Affinity DataIC50:  4.33nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422846(N-(1-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2...)
Affinity DataIC50:  4.35nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423012(US10508109, Example 198 | dimethyl (1-(2-(5-chloro...)
Affinity DataIC50:  4.35nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422957(2-(5-chloro-2,4- dimethoxyphenyl)-7-(4-(2- (pyrrol...)
Affinity DataIC50:  4.40nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422951(3-(4-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2...)
Affinity DataIC50:  4.54nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423045(1-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2- a...)
Affinity DataIC50:  4.88nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422848(US10508109, Example 39 | tert-butyl ((2S)-5-amino-...)
Affinity DataIC50:  4.89nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422871(1-(2-aminoethyl)-3-(1-(2-(5- chloro-2,4-dimethoxyp...)
Affinity DataIC50:  5.14nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422831(2-(5-chloro-2,4- dimethoxyphenyl)-N,N- dimethylimi...)
Affinity DataIC50:  5.15nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423091((methyl(4-((2-(5-chloro-2,4- dimethoxyphenyl)imida...)
Affinity DataIC50:  5.24nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422889(3-(4-chloro-5-methoxy-2-(7- (pyrrolidin-1-yl)imida...)
Affinity DataIC50:  5.31nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422891(2-(5-chloro-2- (cyclopropylmethoxy)-4- methoxyphen...)
Affinity DataIC50:  5.38nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422850((1-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2- ...)
Affinity DataIC50:  5.40nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422816(1-(2-(5-bromo-2,4- dimethoxyphenyl)imidazo[1,2- a]...)
Affinity DataIC50:  5.44nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423020(2-(5-chloro-2,4- dimethoxyphenyl)-7-(4- (ethylsulf...)
Affinity DataIC50:  5.61nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423001(2-(5-chloro-2,4- dimethoxyphenyl)-7-(4- (cycloprop...)
Affinity DataIC50:  5.74nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422859(3-amino-N-(1-(2-(5-chloro-2,4- dimethoxyphenyl)imi...)
Affinity DataIC50:  5.75nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422863(N1-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2- ...)
Affinity DataIC50:  5.85nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423036(N1-(2-(5-chloro-2,4- dimethoxyphenyl)-7-(4- (cyclo...)
Affinity DataIC50:  5.97nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422908(US10508109, Example 99 | methyl 4-(2-(5-chloro-2,4...)
Affinity DataIC50:  6.06nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422818(2-(5-chloro-2,4- dimethoxyphenyl)-7-(pyrrolidin- 1...)
Affinity DataIC50:  6.08nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423054(4-(4-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2...)
Affinity DataIC50:  6.30nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422832(US10508109, Example 23 | tert-butyl (1-(2-(5-chlor...)
Affinity DataIC50:  6.35nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423106(2-(5-chloro-2,4- dimethoxyphenyl)-7-(4- (pyridin-4...)
Affinity DataIC50:  6.37nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423015(2-(5-chloro-2,4- dimethoxyphenyl)-7-(4- (methylsul...)
Affinity DataIC50:  6.40nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423016(US10508109, Example 202 | diethyl (2-(4-(2-(5-chlo...)
Affinity DataIC50:  6.40nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423112((S)-1-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,...)
Affinity DataIC50:  6.49nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423050((4-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2- ...)
Affinity DataIC50:  6.55nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422913(2-(5-chloro-2,4- dimethoxyphenyl)-7-(4-(2- fluoroe...)
Affinity DataIC50:  6.66nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423069(2-(5-chloro-4-methoxy-2- ((methylthio)methoxy)phen...)
Affinity DataIC50:  6.72nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM422963(N-((1-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,...)
Affinity DataIC50:  6.72nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetHistone-lysine N-methyltransferase SUV39H2(Homo sapiens (Human))
Oncotherapy Science

US Patent
LigandPNGBDBM423014(4-(2-(5-chloro-2,4- dimethoxyphenyl)imidazo[1,2- a...)
Affinity DataIC50:  6.74nMAssay Description:Assay buffer (4 μL) was added into all the wells, including test compound and control wells (except for Sinefungin control wells), using the Mul...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 316 total ) | Next | Last >>
Jump to: